A new DTPa-HBV-IPV vaccine co-administered with Hib, compared to a commercially available DTPw-IPV/Hib vaccine co-administered with HBV, given at 6, 10 and 14 weeks following HBV at birth. (Q53900415)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A new DTPa-HBV-IPV vaccine co-administered with Hib, compared to a commercially available DTPw-IPV/Hib vaccine co-administered with HBV, given at 6, 10 and 14 weeks following HBV at birth. |
scientific article |
Statements
A new DTPa-HBV-IPV vaccine co-administered with Hib, compared to a commercially available DTPw-IPV/Hib vaccine co-administered with HBV, given at 6, 10 and 14 weeks following HBV at birth. (English)
1 reference
Gylca R
1 reference
Gylca V
1 reference
Benes O
1 reference
Melnic A
1 reference
Chicu V
1 reference
Weisbecker C
1 reference
Willems P
1 reference
Kaufhold A
1 reference
1 November 2000
1 reference
1 reference
19
1 reference
7-8
1 reference
825-833
1 reference
Identifiers
1 reference